Fluvoxamine withdrawal syndrome
Open accessAbstract
but in elderly patients we have found more problems are created than are solved.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The authors of the fluoxetine case reports did not report information on the duration of the withdrawal syndromes, probably because symptoms were treated by reintroducing fluoxetine or administering other drugs.
“The authors did not report information on the duration of the withdrawal syndromes, probably because symptoms were treated reintroducing fluoxetine [10,57,58] or administering other drugs [1,5] .”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [1]
The case report (Abstract and Additional information; page unavailable) concerns withdrawal from fluvoxamine, not fluoxetine. It describes when symptoms appeared and says the patient continued fluvoxamine, but does not address the duration or treatment of the claimed fluoxetine withdrawal cases. Searches for fluoxetine withdrawal, symptom duration, reintroduction, and other drugs found no supporting passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Central Serotonin and Impulsive Aggression
Coccaro, E. F. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291769 · Cited by 451 · see citing works
Specificity of Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder
Goodman, W. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180077011 · Cited by 311 · see citing works
Amine Hypotheses of Affective Disorders
van Praag, H. M. (1978) · Springer eBooks · doi:10.1007/978-1-4684-3189-6_4 · Cited by 76 · see citing works
Neuroleptic Malignant Syndrome: A Clinical Approach
Gupta, S. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1400 · Cited by 14 · see citing works
Neuroleptic Malignant Syndrome: A Clinical Approach
Addonizio, G., & Susman, V. L. (1991) · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 421 · see citing works
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303 · see citing works
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286 · see citing works
Antidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214 · see citing works
Recognising and managing antidepressant discontinuation symptoms
Haddad, P. M., & Anderson, I. M. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.105.001966 · Cited by 109 · see citing works
The Antidepressant Web: Marketing depression and making medicines work
Medawar, C. (1997) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-1997-10203 · Cited by 92 · see citing works
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00002 · Cited by 87 · see citing works
Adverse events after the abrupt discontinuation of paroxetine
Dominguez, R. A., & Goodnick, P. J. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb02896.x · Cited by 57 · see citing works
Severe psychiatric symptoms associated with paroxetine withdrawal
Bloch, M., Stager, S., Braun, A., & Rubinow, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92691-7 · Cited by 45 · see citing works
Withdrawal and Rebound Symptoms Associated With Abrupt Discontinuation of Venlafaxine
Dallal, A., & Chouinard, G. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00017 · Cited by 32 · see citing works
Withdrawal Hypomania Associated With Paroxetine
Landry, P., & Roy, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00016 · Cited by 20 · see citing works
- Authors
- Szabadi, E.
- Affiliations
- University of Nottingham (GB)
- Corresponding author
- Szabadi, E.
- ORCID
- Szabadi, E.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1992-02
- Volume
- 160
- Issue
- 2
- Pages
- 283-284
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2172112897
- Cited by
- 58
- References
- 5
- Citations by year
- 2019: 1 · 2018: 1 · 2015: 2
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- fluvoxamine, withdrawal syndrome, selective serotonin reuptake inhibitors, antidepressant discontinuation, elderly patients
- MeSH terms
- Adult, Bipolar Disorder, Female, Humans, Obsessive-Compulsive Disorder, Pregnancy, Pregnancy Complications, Substance Withdrawal Syndrome, Fluvoxamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
